A real world study of cell-based quadrivalent influenza vaccine (QIVc) Vs standard egg-based quadrivalent vaccine (QIVe) in preventing influenza-like illness (ILI)
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2018
Price : $35 *
At a glance
- Drugs Influenza vaccine (Optaflu) (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Therapeutic Use
- Sponsors Seqirus
- 17 Dec 2018 New trial record
- 05 Dec 2018 According to a Seqirus media release, the data from this study were presented at the Canadian Immunization Conference (CIC).
- 05 Dec 2018 Results presented in a Seqirus media release.